Literature DB >> 18759129

Inhibition of protein deacetylation by trichostatin A impairs microtubule-kinetochore attachment.

Y Ma1, S Cai, Q Lu, X Lu, Q Jiang, J Zhou, C Zhang.   

Abstract

Inhibition of protein deacetylation arrests cells in mitosis, but the mechanism is unknown. To understand why inhibiting protein deacetylation causes cell cycle arrest, we treated HeLa cells beyond G1/S transition with trichostatin A (TSA), a potent protein deacetylase inhibitor, and found that the cells arrested at prometaphase with ectopic spindles and unaligned chromosomes. The hyper-acetylated cells encountered a serious microtubule (MT)-kinetochore attachment problem, although the kinetochores are intact at ultrastructural level. By immunofluorescence staining of kinetochore proteins, we found that the pericentromeric H3K9Me3-HP1 pathway was disrupted and that the CENP-A-dependent outer plate protein dynamics of kinetochores was greatly diminished by the drug treatment. The treatment also caused the loss of chromosome passenger complex (CPC), the proposed error checking system, from centromere and impaired the microtubule dynamics of the cells. Overall, we propose that deacetylation inhibition impairs MT-kinetochore attachment through disrupting the centromere function and altering the kinetochore composition and MT dynamics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18759129     DOI: 10.1007/s00018-008-8237-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  8 in total

1.  Belinostat and vincristine demonstrate mutually synergistic cytotoxicity associated with mitotic arrest and inhibition of polyploidy in a preclinical model of aggressive diffuse large B cell lymphoma.

Authors:  Aaron P Havas; Kameron B Rodrigues; Anvi Bhakta; Joseph A Demirjian; Seongmin Hahn; Jack Tran; Margarethakay Scavello; Ana A Tula-Sanchez; Yi Zeng; Monika Schmelz; Catharine L Smith
Journal:  Cancer Biol Ther       Date:  2016-10-28       Impact factor: 4.742

2.  Acetylation of RNA processing proteins and cell cycle proteins in mitosis.

Authors:  Carol Chuang; Sue-Hwa Lin; Feilei Huang; Jing Pan; Djuro Josic; Li-yuan Yu-Lee
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

3.  Aurora B is regulated by acetylation/deacetylation during mitosis in prostate cancer cells.

Authors:  Maria Fadri-Moskwik; Kimberly N Weiderhold; Arpaporn Deeraksa; Carol Chuang; Jing Pan; Sue-Hwa Lin; Li-Yuan Yu-Lee
Journal:  FASEB J       Date:  2012-07-02       Impact factor: 5.191

4.  Human RASSF7 regulates the microtubule cytoskeleton and is required for spindle formation, Aurora B activation and chromosomal congression during mitosis.

Authors:  Asha Recino; Victoria Sherwood; Amy Flaxman; Wendy N Cooper; Farida Latif; Andrew Ward; Andrew D Chalmers
Journal:  Biochem J       Date:  2010-09-01       Impact factor: 3.857

5.  DNA-PKcs inhibition impairs HDAC6-mediated HSP90 chaperone function on Aurora A and enhances HDACs inhibitor-induced cell killing by increasing mitotic aberrant spindle assembly.

Authors:  Lan Yu; Yue Lang; Jiaming Guo; Jianming Cai; Zeng-Fu Shang; Benjamin P C Chen
Journal:  Cell Cycle       Date:  2021-01-06       Impact factor: 4.534

6.  Differential distribution of HP1 proteins after trichostatin a treatment influences chromosomal stability in HCT116 and WI-38 cells.

Authors:  Rodrigo González-Barrios; Ernesto Soto-Reyes; Ricardo Quiroz-Baez; Eunice Fabián-Morales; José Díaz-Chávez; Victor Del Castillo; Julia Mendoza; Alejandro López-Saavedra; Clementina Castro; Luis A Herrera
Journal:  Cell Div       Date:  2014-12-30       Impact factor: 5.130

7.  Selective HDAC inhibition by ACY-241 enhances the activity of paclitaxel in solid tumor models.

Authors:  Pengyu Huang; Ingrid Almeciga-Pinto; Matthew Jarpe; John H van Duzer; Ralph Mazitschek; Min Yang; Simon S Jones; Steven N Quayle
Journal:  Oncotarget       Date:  2017-01-10

8.  NudC deacetylation regulates mitotic progression.

Authors:  Carol Chuang; Jing Pan; David H Hawke; Sue-Hwa Lin; Li-yuan Yu-Lee
Journal:  PLoS One       Date:  2013-09-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.